Serum macrophage migration inhibitory factor as a potential biomarker to evaluate therapeutic response in patients with allergic asthma: an exploratory study.

Author: Huiyuan ZHU ¹ ; Shaochun YAN ² ; Jingshuo WU ¹ ; Zhong ZHANG ¹ ; Xiaolin LI ¹ ; Zheng LIU ¹ ; Xing MA ¹ ; Lina ZHOU ¹ ; Lin ZHANG ³ ; Mingming FENG ¹ ; Yiwei GENG ¹ ; Aixin ZHANG ¹ ; Sabina JANCIAUSKIENE ⁴ ; Aiguo XU ⁵
Author Information

1. Department of Pulmonary and Critical Care Medicine, Zhengzhou Second People's Hospital, Zhengzhou Affiliated Hospital of Jinan University, Zhengzhou 450006, China.
2. Department of Cell Biology, School of Basic and Forensic Medicine, Baotou Medical College, Baotou 014040, China.
3. Department of Hematology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
4. Department of Respiratory Medicine, German Center for Lung Research, Hannover Medical School, Hannover 30625, Germany.
5. Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Publication Type:Journal Article
Keywords: Allergic asthma; Eosinophilic inflammation; Fractional exhaled nitric oxide; Immunoglobulin E (IgE); Macrophage migration inhibitory factor (MIF)
From: Journal of Zhejiang University. Science. B 2021;22(6):512-520
CountryChina
Language:English